Abaloparatide

Abaloparatide FDA-Approved for Fragility Fractures in Postmenopausal Women

Abaloparatide FDA-Approved for Fragility Fractures in Postmenopausal Women

By

The FDA has approved abaloparatide injection for postmenopausal women with osteoporosis at an increased risk of fracture

Sign Up for Free e-Newsletters